Funding - September 3, 2014
Funding to heart researcher
Prince Daniel’s funding to young promising scientists will this year be allocated to Lars Maegdefessel for his research on preventing hardening of the arteries. Maegdefessel is doctor of medicine at Karolinska Insitutet in Stockholm and does his research on the mikroRNA molecule and its importance in developing hardening of the arteries. The goal of the […]
Pharma Business - September 3, 2014
MSD changes location
Pharmaceutical company MSD is moving to the new Stockholm life science cluster. The company has been located in Sollentuna, outside of Stockholm, for the last 25 years but will change locations to Hagastaden during the spring of 2015. “For MSD in Sweden it is important to be part of the development of the new cluster […]
Pharma Business - September 2, 2014
Novo creates investment unit
Novo Nordisk’s holding company Novo A/S is setting up a new unit for major acquisitions that can invest ten billion DKK annually, according to web magazine News Øresund. The ambition is to buy companies within the pharmaceutical, biotech and medtech sector in the Nordic countries and other parts of Europe. “We have decided to construct […]
Financing - September 1, 2014
Orexo completes private placement of SEK 346.5 million
Orexo AB has announced that its private placement of 2,493,046 Orexo shares has been completed. The placement included all Orexo shares held in treasury by the company in addition to newly issued shares. The price of SEK 139 per share was determined through a book-building procedure, resulting in total cash proceeds of approximately SEK 346.5m before […]
Uncategorized - August 29, 2014
New cancer research center opened
The K.G. Jebsen Center for colorectal cancer research has now been opened. The center is led by Ragnhild A. Lothe, co-director Centre for Cancer Biomedicine, University of Oslo. The colorectal cancer research center will focus on improving the methods for diagnosis and treatment of colorectal cancer and will receive NOK 16 mill over a 4-year […]
Global report - August 29, 2014
Ebola vaccine to be tested
GlaxoSmithKline plans to take its ebola vaccine candidate to clinical trials and test it in Great Britain, Gambia and Mali. A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, states GSK, as part of a series of safety trials of potential vaccines aimed […]
